急性病成人宽松与保守氧疗的死亡率和发病率:IOTA系统综述与荟萃分析
结果显示,宽松氧疗策略与院内、30天及最长随访死亡率升高相关,发病率结局两组相似;证据质量高,支持保守给氧。
要点
- 急性病成人宽松氧疗较保守策略增加院内、30天及最长随访死亡率。
- 发病率结局两组相似,宽松氧疗未改善其他患者重要结局。
- 补充氧疗在SpO2高于94-96%范围时可能转为不利,支持保守给氧。
核心结论
- 急性病成人中,高质量证据显示宽松氧疗增加死亡率且不改善其他患者重要结局。
- 补充氧疗在SpO2高于94-96%范围时可能变得不利。
- 结果支持保守的氧疗给药策略。
研究设计与样本
- IOTA系统综述与荟萃分析,检索Cochrane Central Register of Controlled Trials、MEDLINE、Embase、HealthSTAR、LILACS、PapersFirst及WHO国际临床试验注册库,检索自建库至2017年10月25日。
- 纳入比较宽松与保守氧疗的随机对照试验,对象为年龄≥18岁的急性病成人;排除仅限慢性呼吸疾病或精神疾病、体外生命支持、高压氧治疗或择期手术患者。
- 采用随机效应荟萃分析,并用GRADE方法评估证据质量;研究注册号PROSPERO CRD42017065697。
主要发现
- 发病率结局两组相似。
- 试验序贯分析、亚组分析和敏感性分析显示结果稳健;试验中基线SpO2中位数96%(范围94-99%,IQR 96-98)。
关键数值与推荐
- 补充氧疗可能在SpO2高于94-96%范围时不利。
临床怎么用
- 对急性病成人采用保守氧疗策略,避免宽松给氧。
- 关注SpO2,补充氧疗在SpO2高于94-96%范围时可能不利。
- 宽松氧疗未被证明改善发病率结局,不应以宽松给氧追求其他获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically reviewed the efficacy and safety of liberal versus conservative oxygen therapy in acutely ill adults. METHODS: In the Improving Oxygen Therapy in Acute-illness (IOTA) systematic review and meta-analysis, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, HealthSTAR, LILACS, PapersFirst, and the WHO International Clinical Trials Registry from inception to Oct 25, 2017, for randomised controlled trials comparing liberal and conservative oxygen therapy in acutely ill adults (aged ≥18 years). Studies limited to patients with chronic respiratory diseases or psychiatric disease, patients on extracorporeal life support, or patients treated with hyperbaric oxygen therapy or elective surgery were excluded. We screened studies and extracted summary estimates independently and in duplicate. We also extracted individual patient-level data from survival curves. The main outcomes were mortality (in-hospital, at 30 days, and at longest follow-up) and morbidity (disability at longest follow-up, risk of hospital-acquired pneumonia, any hospital-acquired infection, and length of hospital stay) assessed by random-effects meta-analyses. We assessed quality of evidence using the grading of recommendations assessment, development, and evaluation approach. This study is registered with PROSPERO, number CRD42017065697. FINDINGS: 25 randomised controlled trials enrolled 16 037 patients with sepsis, critical illness, stroke, trauma, myocardial infarction, or cardiac arrest, and patients who had emergency surgery. Compared with a conservative oxygen strategy, a liberal oxygen strategy (median baseline saturation of peripheral oxygen [SpO2] across trials, 96% [range 94-99%, IQR 96-98]) increased mortality in-hospital (relative risk [RR] 1·21, 95% CI 1·03-1·43, I2=0%, high quality), at 30 days (RR 1·14, 95% CI 1·01-1·29, I2=0%, high quality), and at longest follow-up (RR 1·10, 95% CI 1·00-1·20, I2=0%, high quality). Morbidity outcomes were similar between groups. Findings were robust to trial sequential, subgroup, and sensitivity analyses. INTERPRETATION: In acutely ill adults, high-quality evidence shows that liberal oxygen therapy increases mortality without improving other patient-important outcomes. Supplemental oxygen might become unfavourable above an SpO2 range of 94-96%. These results support the conservative administration of oxygen therapy. FUNDING: None.
引用
- Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018. PMID: 29726345. doi:10.1016/S0140-6736(18)30479-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。